Ignacio Martín Granizo

Suggest Changes
Learn More
INTRODUCTION GIDEON is a non-interventional, prospective, international study that evaluated the safety of sorafenib in patients with unresectable hepatocellular carcinoma (HCC) in daily clinical(More)
  • 1